EVGN - Evogene Ltd.

NasdaqGM - NasdaqGM Delayed Price. Currency in USD
2.69
0.00 (0.00%)
At close: 3:32PM EST
Stock chart is not supported by your current browser
Previous Close2.69
Open2.55
Bid2.30 x 1200
Ask4.02 x 1100
Day's Range2.55 - 2.71
52 Week Range2.50 - 4.20
Volume2
Avg. Volume5,403
Market Cap64.768M
Beta (3Y Monthly)0.79
PE Ratio (TTM)N/A
EPS (TTM)-0.83
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est8.00
Trade prices are not sourced from all markets
  • Associated Press2 days ago

    Evogene: 3Q Earnings Snapshot

    On a per-share basis, the Rehovot, Israel-based company said it had a loss of 19 cents. The agricultural company posted revenue of $367,000 in the period. The company's shares closed at $2.73. A year ago, ...

  • GlobeNewswire2 days ago

    Evogene Reports Third Quarter 2018 Financial Results

    REHOVOT, Israel, Nov. 14, 2018 -- Conference call and webcast, today at 9:00 am Eastern Time Evogene Ltd. (NASDAQ, TASE: EVGN), a leading biotechnology company developing.

  • GlobeNewswire9 days ago

    Biomica Announces the Addition of Internationally Renowned Experts in the Fields of Gastroenterology and the Human Microbiome to its Scientific Advisory Board

    REHOVOT, Israel, Nov. 06, 2018 (GLOBE NEWSWIRE) --  Biomica, a subsidiary of Evogene Ltd. (NASDAQ, TASE: EVGN), an emerging biopharmaceutical company developing innovative microbiome-based therapeutics announced today that internationally renowned experts have joined the company’s scientific advisory board. The experts will join Prof. Yehuda Ringel, Biomica co-founder and CSO, an internationally recognized thought leader in the field of the functional gastrointestinal disorders and the intestinal microbiome, in order to support the company’s upcoming steps towards its clinical development. Prof. Willem M De Vos is Professor and Chair of Microbiology at Wageningen University, the Netherlands and Professor of Human Microbiomics at the University of Helsinki, Finland, where he also served as Finland Distinguished and Academy Professor.

  • GlobeNewswire18 days ago

    Evofuel and Fantini s.r.l Announce Breakthrough in Mechanical Harvesting for Castor Bean

    Evofuel Ltd., a wholly owned subsidiary of Evogene Ltd. (NASDAQ, TASE: EVGN), focused on securing the global demand for stable castor oil supply and Fantini s.r.l., a leading manufacturer and distributor of agricultural equipment, announced today the successful development of a mechanical harvesting solution for castor bean plants.  The solution developed has shown a significant decrease in yield losses, from up to 50% with the current solutions to as low as 5% with the combination of the harvester and Evofuel proprietary castor varieties and growth protocols in two consecutive year field trials in Israel during 2017-2018. The global castor oil and derivatives market is expected to reach USD 2.3 billion by 20241.

  • GlobeNewswire23 days ago

    Evogene Financial Results for the Third Quarter of 2018 Earnings Announcement Schedule

    REHOVOT, Israel, Oct. 24, 2018 -- Evogene Ltd. (NASDAQ, TASE: EVGN), a leading biotechnology company developing novel products for life science markets, announced today that it.

  • GlobeNewswire2 months ago

    Evogene Announces a Significant Milestone in its Next Generation Herbicide Pipeline

    Evogene Ltd. (NASDAQ, TASE: EVGN), a leading biotechnology company developing novel products for life science markets, announced today a significant milestone in its next generation herbicide pipeline. Evogene’s Ag-Chemicals division demonstrated biological proof in lab assays that Evogene discovered molecule families bind to essential target proteins representing new MoA’s (Mode-of-Action). Herbicides are weed killing chemicals, part of the general pesticide and crop protection market.

  • Associated Press3 months ago

    Evogene: 2Q Earnings Snapshot

    On a per-share basis, the Rehovot, Israel-based company said it had a loss of 19 cents. The agricultural company posted revenue of $379,000 in the period. The company's shares closed at $2.88. A year ago, ...

  • ACCESSWIRE3 months ago

    Evogene Ltd to Host Earnings Call

    NEW YORK, NY / ACCESSWIRE / August 8, 2018 / Evogene Ltd (NASDAQ: EVGN ) will be discussing their earnings results in their Q2 Earnings Call to be held on August 8, 2018 at 9:00 AM Eastern Time. To listen ...

  • ACCESSWIRE6 months ago

    Blog Exposure - Evogene Signs Collaboration Agreement with BASF for Development of Novel Insecticides

    LONDON, UK / ACCESSWIRE / May 31, 2018 / If you want access to our free research report on Evogene Ltd (NASDAQ: EVGN), all you need to do is sign up now by clicking the following link www.active-investors.com/registration-sg/?symbol=EVGN as the Company's latest news hit the wire. On May 29, 2018, the Company, which is a leading biotechnology organization developing novel products for life science markets, and BASF, which is one of the world's leading chemical Companies, declared on May 29, 2018, that they have signed a new collaboration agreement for the development of novel insecticides based on new binding areas (Site-of-Action or ‘SoA') on key insecticidal target proteins. Active-Investors.com is currently working on the research report for Oncobiologics, Inc. (NASDAQ: ONS), which also belongs to the Healthcare sector as the Company Evogene.

  • Associated Press6 months ago

    Evogene: 1Q Earnings Snapshot

    On a per-share basis, the Rehovot, Israel-based company said it had a loss of 21 cents. The agricultural company posted revenue of $366,000 in the period. The company's shares closed at $3.10. A year ago, ...

  • Associated Press9 months ago

    Evogene reports 4Q loss

    The Rehovot, Israel-based company said it had a loss of 24 cents per share. The agricultural company posted revenue of $734,000 in the period. For the year, the company reported that its loss widened to ...

  • ACCESSWIRE9 months ago

    Evogene Ltd to Host Earnings Call

    NEW YORK, NY / ACCESSWIRE / February 28, 2018 / Evogene Ltd (NASDAQ: EVGN ) will be discussing their earnings results in their Q4 Earnings Call to be held on February 28, 2018 at 9:00 AM Eastern Time. ...